M&A Deal Summary

Apposite Capital Acquires Octavia House Schools

On January 1, 2024, private equity firm Apposite Capital acquired education company Octavia House Schools

Acquisition Highlights
  • This is Apposite Capital’s 1st transaction in the Education sector.
  • This is Apposite Capital’s 13th transaction in the United Kingdom.

M&A Deal Summary

Date 2024-01-01
Target Octavia House Schools
Sector Education
Buyer(s) Apposite Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

Octavia House Schools

London, United Kingdom
Octavia House Schools is a provider of therapeutic education services. Their seamless therapeutic approach means that therapists and teachers 'work as one' to support pupils' social, emotional, behavioural and educational development. Octavia House Schools is based in London, United Kingdom.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Apposite Capital

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2006
Size Small
Type Sector Focused
DESCRIPTION

Apposite Capital is a private investment firm focused on investing in growth companies in the healthcare sector. The Firm targets UK-based, revenue generating businesses and looks to invest £10 to £25 million over the life of an investment. Specific areas of interest include rehab services, primary and acute care companies, health related software solutions and IT, elderly and specialist healthcare services, medical products, and pharmaceuticals. Apposite Capital was established in 2006 and is based in London.


DEAL STATS #
Overall 19 of 19
Sector: Education M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 10 of 10
Country: United Kingdom M&A 13 of 13
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-14 Kelso Pharma

Kelso, United Kingdom

Kelso Pharma is a business committed to bringing innovative specialty medicines to the European healthcare markets, to provide meaningful benefits to patients and create added value for healthcare stakeholders. Kelso Pharma was founded in 2022 and is based in Kelso, United Kingdom.

Buy -